Fast Facts: CAR T-Cell Therapy: Insight into current and future applications
- ISBN-10
- 3318067423
- ISBN-13
- 9783318067422
- Category
- Medical
- Pages
- 72
- Language
- English
- Published
- 2021-01-26
- Publisher
- Karger Medical and Scientific Publishers
- Authors
- R.J. Buka, A.J. Kansagra
Description
Chimeric antigen receptor (CAR) T cells are genetically engineered immune cells that can seek out and destroy cancer cells. The results from their use in cancer immunotherapy have been very promising, but treatment is often associated with frequent, serious short-term toxicities. 'Fast Facts: CAR-T Therapy' explains what CAR T cells are and how they were developed, discusses the results of clinical trials and the management of toxicities, and outlines future improvements and applications. It is ideal reading for any healthcare professional wanting to know more about this exciting therapeutic field. Table of Contents: • CAR T cells • Clinical application • Practical aspects • Future directions
Get the book
Other editions
-
- 2021-02-28
- 72 pages
- Paperback
- Karger Medical and Scientific Publishers
Similar books
-
Fast Facts: CAR T-Cell Therapy in Diffuse Large B-Cell Lymphoma: A practical resource for nurses
By R.J. Buka, D. MoloneyDiffuse large B-cell lymphoma (DLBCL) is the most common form of high-grade non-Hodgkin lymphoma.
-
Fast Facts: Immuno-Oncology: 2nd edition
By Stephen Clarke, Bob T. LiThis second edition of 'Fast Facts: Immuno-Oncology' takes you from the fundamentals of immunology through to the new concepts of immunoediting and immunotherapy and likely future directions.
-
Fast Facts: Gene Therapy
By Roland Herzog, Linda PopplewellThis book will be informative and of value to health professionals, researchers, students and anyone with an interest in this exciting and fast-moving area.
-
Fast Facts: Peripheral T-cell Lymphoma
By Fox, Matthew, FrancineFoss F, Pro B, Miles Prince H et al. Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma. Cancer Med 2017;6: 36–44. 11. Foss F, Advani R, Duvic M et al.
-
Fast Facts: Multiple Myeloma and Plasma Cell Dyscrasias
By Karthik Ramasamy, Sagar LonialIn patients with IgM MGUS, the presence of both the L265P mutation in the Myd88 gene and M protein levels above 1.5 g/dL is associated with a 45% risk of progression to Waldenström's macroglobulinemia, chronic lymphocytic leukemia or ...
-
Fast Facts: Acute Lymphoblastic Leukemia
By M. Austin, B. Wrench, A. CastletonFast Facts: Acute Lymphoblastic Leukemia covers the epidemiology, etiology, diagnosis and classification of ALL as well as the measurement of minimal residual disease to determine prognosis.
-
Fast Facts: Lymphoma
By Grapham P. Collins, Toby A. Eyre, Eliza HawkesThis new edition of 'Fast Facts: Lymphoma' has been updated to include recent changes in our understanding of lymphoma biology as well as improvements in diagnostics and therapeutics.
-
Fast Facts: Lymphoma
By C. Hatton, G. Collins, J. SweetenhamThis third edition of our bestselling 'Fast Facts: Lymphoma' distills the most important aspects of diagnosis and management into an up-to-date and highly accessible well-illustrated overview that includes: • a clear outline of the nature ...
-
Fast Facts: Lymphoma
By Chris Hatton, Graham Collins, John SweetenhamThe aim is to ensure that the entire target area is included in the radiation field, while normal organs receive as little radiation as possible. To achieve this, several X-ray, CT and MRI studies are usually carried out.
-
Fast Facts: Cutaneous T-cell Lymphoma
By Paul L Haun, Julia J ScarisbrickMF, mycosis fungoides. lung carcinoma, colonic adenocarcinoma and non-Hodgkin's lymphoma, which do not appear to be ... nodal CD30+ anaplastic large cell lymphoma) and B-cell (Hodgkin's disease, chronic lymphocytic leukemia) origins.